Different Doses of Oral Melatonin Supplements in Chronic Kidney Disease (CKD)-Associated Sleep Disorders

Recruiting

Phase 2

Phase 3

MelatoninDifferent Doses of Oral Melatonin Supplements in Chronic Kidney Disease (CKD)-Associated Sleep Disorders

Sponsor:

Southeast Renal Research Institute

Code:

NCT01922999

Conditions

End Stage Renal Disease

Chronic Kidney Disease

Sleep Disorder

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Accepted

Interventions

Melatonin

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-07-02. This information was provided to ClinicalTrials.gov by Southeast Renal Research Institute on 2017-01-24.